Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | UTI | Common Stock, $0.0001 par value | Options Exercise | $94.2K | +30K | +23.4% | $3.14 | 158K | Nov 27, 2024 | Direct | |
transaction | UTI | Common Stock, $0.0001 par value | Sale | -$777K | -30K | -18.96% | $25.92 | 128K | Nov 27, 2024 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | UTI | Director Stock Option (Right to Buy) | Options Exercise | $0 | -30K | -100% | $0.00 | 0 | Nov 27, 2024 | Common Stock | 30K | $3.14 | Direct |
Id | Content |
---|---|
F1 | The prices reported in Column 4 reflect a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.59 to $26.16. The reporting person undertakes to provide to the issuer or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. |